Hematological Malignancies

Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.

David S. Siegel, MD, PhD
Video Categories: Hematological Malignancies

Improving Myeloma Outcomes

Dr. Ajai Chari discusses the ultimate goal of improving therapy for myeloma patients. He mentions the COMPASS study, which is working to collect a database of clinical and scientific information on 1000 patients. In the interim, there are some clues, such as an understanding of certain high-molecular-risk patients and some [ Read More ]

Ajai Chari, MD
Video Categories: Hematological Malignancies

Treating Cancer: A Changing Paradigm

Dr. Vij delves into the role of bioinformatics in identifying targets for drug development.

Ravi Vij, MD
Video Categories: Hematological Malignancies

Sign me up!
Friends link: prep4certs
070-411 Braindumps
VCP-550 Braindumps
70-483 Braindumps
HP2-K38
642-997
PK0-003
BH0-013
640-875
C4040-129
JN0-332
E20-547
70-462 Braindumps
400-101 Braindumps
070-461 Braindumps